CSTEVSNRSN• 3 Months (Normalized)
CSTE vs NRSN (Caesarstone Ltd. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Jun 30 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CSTE Performance $2.79
+32.86%
Caesarstone Ltd.
Normalized Baseline0.00%
NRSN Performance $7.4
+927.78%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-894.92 pts
NRSN outperforming by 894.92 percentage points
CSTENRSN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CSTE NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(60 dates)
| Date | CSTE Price | CSTE Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $2.79 | +32.86% | $7.40 | +927.78% | -894.92% |
| Sep 22, 2026 | $- | $7.18 | +897.22% | - | |
| Sep 21, 2026 | $2.77 | +31.90% | $6.62 | +819.44% | -787.54% |
| Sep 18, 2026 | $2.87 | +36.67% | $6.35 | +781.94% | -745.27% |
| Sep 17, 2026 | $2.81 | +33.81% | $6.72 | +833.33% | -799.52% |
| Sep 16, 2026 | $2.87 | +36.67% | $6.49 | +801.39% | -764.72% |
| Sep 15, 2026 | $3.01 | +43.33% | $7.03 | +876.39% | -833.06% |
| Sep 14, 2026 | $3.13 | +49.05% | $6.90 | +858.33% | -809.28% |
| Sep 11, 2026 | $3.19 | +51.90% | $0.35 | -51.81% | +103.71% |
| Sep 10, 2026 | $3.18 | +51.43% | $0.33 | -53.89% | +105.32% |
| Sep 09, 2026 | $3.01 | +43.33% | $0.40 | -44.31% | +87.64% |
| Sep 08, 2026 | $3.10 | +47.62% | $0.42 | -41.94% | +89.56% |
| Sep 04, 2026 | $2.97 | +41.43% | $0.51 | -29.03% | +70.46% |
| Sep 03, 2026 | $3.05 | +45.24% | $0.40 | -44.17% | +89.41% |
| Sep 02, 2026 | $3.00 | +42.86% | $0.41 | -42.92% | +85.78% |
Page 1 of 4